{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:13:35Z","timestamp":1793222015688,"version":"4.5.0"},"reference-count":81,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T00:00:00Z","timestamp":1625270400000},"content-version":"vor","delay-in-days":32,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011925","name":"ESHRE","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>STUDY QUESTION<\/jats:title>\n                  <jats:p>Is it possible to define a set of performance indicators (PIs) for clinical work in ART, which can create competency profiles for clinicians and for specific clinical process steps?<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>SUMMARY ANSWER<\/jats:title>\n                  <jats:p>The current paper recommends six PIs to be used for monitoring clinical work in ovarian stimulation for ART, embryo transfer, and pregnancy achievement: cycle cancellation rate (before oocyte pick-up (OPU)) (%CCR), rate of cycles with moderate\/severe ovarian hyperstimulation syndrome (OHSS) (%mosOHSS), the proportion of mature (MII) oocytes at ICSI (%MII), complication rate after OPU (%CoOPU), clinical pregnancy rate (%CPR), and multiple pregnancy rate (%MPR).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                  <jats:p>PIs are objective measures for evaluating critical healthcare domains. In 2017, ART laboratory key PIs (KPIs) were defined.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                  <jats:p>A list of possible indicators was defined by a working group. The value and limitations of each indicator were confirmed through assessing published data and acceptability was evaluated through an online survey among members of ESHRE, mostly clinicians, of the special interest group Reproductive Endocrinology.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                  <jats:p>The online survey was open for 5\u2009weeks and 222 replies were received. Statements (indicators, indicator definitions, or general statements) were considered accepted when \u226570% of the responders agreed (agreed or strongly agreed). There was only one round to seek levels of agreement between the stakeholders.<\/jats:p>\n                  <jats:p>Indicators that were accepted by the survey responders were included in the final list of indicators. Statements reaching less than 70% were not included in the final list but were discussed in the paper.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                  <jats:p>Cycle cancellation rate (before OPU) and the rate of cycles with moderate\/severe OHSS, calculated on the number of started cycles, were defined as relevant PIs for monitoring ovarian stimulation. For monitoring ovarian response, trigger and OPU, the proportion of MII oocytes at ICSI and complication rate after OPU were listed as PIs: the latter PI was defined as the number of complications (any) that require an (additional) medical intervention or hospital admission (apart from OHSS) over the number of OPUs performed. Finally, clinical pregnancy rate and multiple pregnancy rate were considered relevant PIs for embryo transfer and pregnancy. The defined PIs should be calculated every 6\u2009months or per 100 cycles, whichever comes first. Clinical pregnancy rate and multiple pregnancy rate should be monitored more frequently (every 3\u2009months or per 50 cycles). Live birth rate (LBR) is a generally accepted and an important parameter for measuring ART success. However, LBR is affected by many factors, even apart from ART, and it cannot be adequately used to monitor clinical practice. In addition to monitoring performance in general, PIs are essential for managing the performance of staff over time, and more specifically the gap between expected performance and actual performance measured. Individual clinics should determine which indicators are key to the success in their organisation based on their patient population, protocols, and procedures, and as such, which are their KPIs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                  <jats:p>The consensus values are based on data found in the literature and suggestions of experts. When calculated and compared to the competence\/benchmark limits, prudent interpretation is necessary taking into account the specific clinical practice of each individual centre.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                  <jats:p>The defined PIs complement the earlier defined indicators for the ART laboratory. Together, both sets of indicators aim to enhance the overall quality of the ART practice and are an essential part of the total quality management. PIs are important for education and can be applied during clinical subspecialty.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                  <jats:p>This paper was developed and funded by ESHRE, covering expenses associated with meetings, literature searches, and dissemination. The writing group members did not receive payment.<\/jats:p>\n                  <jats:p>Dr G.G. reports personal fees from Merck, MSD, Ferring, Theramex, Finox, Gedeon-Richter, Abbott, Biosilu, ReprodWissen, Obseva, PregLem, and Guerbet, outside the submitted work. Dr A.D. reports personal fees from Cook, outside the submitted work; Dr S.A. reports starting a new employment in May 2020 at Vitrolife. Previously, she has been part of the Nordic Embryology Academic Team, with meetings were sponsored by Gedeon Richter. The other authors have no conflicts of interest to declare.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>DISCLAIMER<\/jats:title>\n                  <jats:p>This document represents the views of ESHRE, which are the result of consensus between the relevant ESHRE stakeholders and where relevant based on the scientific evidence available at the time of preparation.<\/jats:p>\n                  <jats:p>The recommendations should be used for informational and educational purposes. They should not be interpreted as setting a standard of care, or be deemed inclusive of all proper methods of care nor exclusive of other methods of care reasonably directed to obtaining the same results. They do not replace the need for application of clinical judgment to each individual presentation, nor variations based on locality and facility type.<\/jats:p>\n                  <jats:p>Furthermore, ESHREs recommendations do not constitute or imply the endorsement, recommendation, or favouring of any of the included technologies by ESHRE.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/hropen\/hoab022","type":"journal-article","created":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T11:19:45Z","timestamp":1620904785000},"source":"Crossref","is-referenced-by-count":66,"title":["The Maribor consensus: report of an expert meeting on the development of performance indicators for clinical practice in ART"],"prefix":"10.1093","volume":"2021","author":[{"name":"ESHRE Clinic PI Working Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veljko","family":"Vlaisavljevic","sequence":"additional","affiliation":[{"name":"IVF Adria Consulting D.O.O., Maribor, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Apter","sequence":"additional","affiliation":[{"name":"Livio Fertilitetscentrum, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Capalbo","sequence":"additional","affiliation":[{"name":"Igenomix Italy, Marostica, Italy"},{"name":"DAHFMO, Unit of Histology and Medical Embryology, Sapienza, University of Rome, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"D'Angelo","sequence":"additional","affiliation":[{"name":"Wales Fertility Institute, Swansea Bay Health Board, University Hospital of Wales, Cardiff University, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Gianaroli","sequence":"additional","affiliation":[{"name":"Societa Italiana Studi di Medicina della Riproduzione, S.I.S.Me.R. Reproductive Medicine Institute, Bologna, Emilia-Romagna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0606-5804","authenticated-orcid":false,"given":"Georg","family":"Griesinger","sequence":"additional","affiliation":[{"name":"Department of Gynecological Endocrinology and Reproductive Medicine, University Hospital Schleswig-Holstein, Lubeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0031-9460","authenticated-orcid":false,"given":"Efstratios M","family":"Kolibianakis","sequence":"additional","affiliation":[{"name":"Unit for Human Reproduction, 1st Department of ObGyn, Medical School, Aristotle University, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3865-7142","authenticated-orcid":false,"given":"George","family":"Lainas","sequence":"additional","affiliation":[{"name":"Eugonia Assisted Reproduction Unit, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonko","family":"Mardesic","sequence":"additional","affiliation":[{"name":"Sanatorium Pronatal, Prague 4, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Motrenko","sequence":"additional","affiliation":[{"name":"Human Reproduction Centre Budva, Budva, Montenegro"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sari","family":"Pelkonen","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Oulu University Hospital, University of Oulu, Medical Research Center, PEDEGO Research Unit, Oulu, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5236-2586","authenticated-orcid":false,"given":"Daniela","family":"Romualdi","sequence":"additional","affiliation":[{"name":"Department of Woman and Child Health and Public Health, Woman Health Area, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy"},{"name":"Department of Woman and Child Health, Azienda Ospedaliera Card. Panico, Tricase, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8046-6799","authenticated-orcid":false,"given":"Nathalie","family":"Vermeulen","sequence":"additional","affiliation":[{"name":"ESHRE Central Office, Grimbergen, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8832-2888","authenticated-orcid":false,"given":"Kelly","family":"Tilleman","sequence":"additional","affiliation":[{"name":"Department for reproductive medicine, Universitair Ziekenhuis Gent, Gent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,7,3]]},"reference":[{"key":"2021071903190353000_hoab022-B1","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/humrep\/14.9.2181","article-title":"Severe OHSS: an \u2018epidemic\u2019 of severe OHSS: a price we have to pay?","volume":"14","author":"Abramov","year":"1999","journal-title":"Hum Reprod"},{"key":"2021071903190353000_hoab022-B2","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.fertnstert.2018.06.039","article-title":"International Committee for Monitoring Assisted Reproductive Technology: world report on assisted reproductive technology, 2011","volume":"110","author":"Adamson","year":"2018","journal-title":"Fertil Steril"},{"key":"2021071903190353000_hoab022-B3","first-page":"CD001750","article-title":"Gonadotrophin-releasing hormone antagonists for assisted reproductive technology","author":"Al-Inany","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"2021071903190353000_hoab022-B4","first-page":"Cd001750","article-title":"Gonadotrophin-releasing hormone antagonists for assisted reproductive technology","volume":"4","author":"Al-Inany","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2021071903190353000_hoab022-B5","author":"American Institute of Ultrasound in Medicine","year":"2017"},{"key":"2021071903190353000_hoab022-B6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.fertnstert.2010.07.1054","article-title":"Clinical complications after transvaginal oocyte retrieval in 7,098 IVF cycles","volume":"95","author":"Aragona","year":"2011","journal-title":"Fertil Steril"},{"key":"2021071903190353000_hoab022-B7","doi-asserted-by":"crossref","first-page":"432","DOI":"10.5694\/j.1326-5377.1988.tb139565.x","article-title":"In-vitro fertilization pregnancies in Australia and New Zealand, 1979\u20131985","volume":"148","author":"Australian In-Vitro Fertilization Collaborative Group","year":"1988","journal-title":"Med J Austral"},{"key":"2021071903190353000_hoab022-B8","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1093\/humupd\/dmx021","article-title":"The diagnosis of male infertility: an analysis of the evidence to support the development of global WHO guidance-challenges and future research opportunities","volume":"23","author":"Barratt","year":"2017","journal-title":"Hum Reprod Update"},{"key":"2021071903190353000_hoab022-B9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/BF01204444","article-title":"Complications of transvaginal ultrasound-directed follicle aspiration: a review of 2670 consecutive procedures","volume":"10","author":"Bennett","year":"1993","journal-title":"J Assist Reprod Genet"},{"key":"2021071903190353000_hoab022-B10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1472-6483(10)60200-3","article-title":"Complications related to ovarian stimulation and oocyte retrieval in 4052 oocyte donor cycles","volume":"17","author":"Bodri","year":"2008","journal-title":"Reprod Biomed Online"},{"key":"2021071903190353000_hoab022-B11","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.rbmo.2015.08.005","article-title":"Is the time interval between HCG administration and oocyte retrieval associated with oocyte retrieval rate?","volume":"31","author":"Bosdou","year":"2015","journal-title":"Reprod Biomed Online"},{"key":"2021071903190353000_hoab022-B12","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2008.02.010","article-title":"An oocyte pick-up procedure complicated with pseudoaneurysm of the internal iliac artery","volume":"90","author":"Bozdag","year":"2008","journal-title":"Fertil Steril"},{"key":"2021071903190353000_hoab022-B13","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1093\/humrep\/dev201","article-title":"Effectiveness and safety as outcome measures in reproductive medicine","volume":"30","author":"Braakhekke","year":"2015","journal-title":"Hum Reprod"},{"key":"2021071903190353000_hoab022-B14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fendo.2019.00181","article-title":"Individualization of FSH doses in assisted reproduction: facts and fiction","volume":"10","author":"Broekmans","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2021071903190353000_hoab022-B15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/humrep\/17.2.341","article-title":"The influence of the depth of embryo replacement into the uterine cavity on implantation rates after IVF: a controlled, ultrasound-guided study","volume":"17","author":"Coroleu","year":"2002","journal-title":"Hum Reprod"},{"key":"2021071903190353000_hoab022-B16","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0015-0282(16)49898-5","article-title":"Empty follicle syndrome","volume":"46","author":"Coulam","year":"1986","journal-title":"Fertil Steril"},{"key":"2021071903190353000_hoab022-B17","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1093\/humrep\/det056","article-title":"Quality indicators for all dimensions of infertility care quality: consensus between professionals and patients","volume":"28","author":"Dancet","year":"2013","journal-title":"Hum Reprod"},{"key":"2021071903190353000_hoab022-B18","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.fertnstert.2013.12.045","article-title":"\"Patient-centered fertility treatment\": what is required?","volume":"101","author":"Dancet","year":"2014","journal-title":"Fertil Steril"},{"key":"2021071903190353000_hoab022-B19","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/humupd\/dmq004","article-title":"The patients' perspective on fertility care: a systematic review","volume":"16","author":"Dancet","year":"2010","journal-title":"Hum Reprod Update"},{"key":"2021071903190353000_hoab022-B20","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/humrep\/dey242","article-title":"ART in Europe, 2014: results generated from European registries by ESHRE: The European IVF-monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE)","volume":"33","author":"De Geyter","year":"2018","journal-title":"Hum Reprod"},{"key":"2021071903190353000_hoab022-B21","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/humrep\/dew016","article-title":"Revised guidelines for good practice in IVF laboratories","volume":"31","author":"De los Santos","year":"2016","journal-title":"Hum Reprod"},{"key":"2021071903190353000_hoab022-B22","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1093\/humrep\/deu181","article-title":"Quality control of training and performance in embryo transfer: time to broadcast LC CUSUM and CUSUM tests","volume":"29","author":"Dessolle","year":"2014","journal-title":"Hum Reprod"},{"key":"2021071903190353000_hoab022-B23","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1093\/humrep\/der251","article-title":"An OHSS-Free Clinic by segmentation of IVF treatment","volume":"26","author":"Devroey","year":"2011","journal-title":"Hum Reprod"},{"key":"2021071903190353000_hoab022-B24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.23736\/S0026-4784.18.04347-2","article-title":"Cumulative live birth rates in in-vitro fertilization","volume":"71","author":"Drakopoulos","year":"2019","journal-title":"Minerva Ginecol"},{"key":"2021071903190353000_hoab022-B25","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/humrep\/det457","article-title":"ESHRE guideline: management of women with endometriosis","volume":"29","author":"Dunselman","year":"2014","journal-title":"Hum Reprod"},{"key":"2021071903190353000_hoab022-B26","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/humrep\/dew082","article-title":"International Committee for Monitoring Assisted Reproductive Technologies world report: Assisted Reproductive Technology 2008, 2009 and 2010","volume":"31","author":"Dyer","year":"2016","journal-title":"Hum Reprod"},{"key":"2021071903190353000_hoab022-B27","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.fertnstert.2004.01.044","article-title":"Thrombocythemia and hemoperitoneum after transvaginal oocyte retrieval for in vitro fertilization","volume":"82","author":"El-Shawarby","year":"2004","journal-title":"Fertil Steril"},{"key":"2021071903190353000_hoab022-B28","doi-asserted-by":"crossref","first-page":"hoaa052","DOI":"10.1093\/hropen\/hoaa052","article-title":"ESHRE guideline: female fertility preservation","volume":"2020","author":"ESHRE Guideline Group on Female Fertility Preservation","year":"2020","journal-title":"Hum Reprod Open"},{"key":"2021071903190353000_hoab022-B29","doi-asserted-by":"crossref","first-page":"hox011","DOI":"10.1093\/hropen\/hox011","article-title":"The Vienna consensus: report of an expert meeting on the development of art laboratory performance indicators","volume":"2017","author":"ESHRE Special Interest Group of Embryology, Alpha Scientists in Reproductive Medicine","year":"2017","journal-title":"Hum Reprod Open"},{"key":"2021071903190353000_hoab022-B30","doi-asserted-by":"crossref","first-page":"hoz025","DOI":"10.1093\/hropen\/hoz025","article-title":"Recommendations for good practice in ultrasound: oocyte pick up","volume":"2019","author":"Eshre Working Group On Ultrasound In","year":"2019","journal-title":"Hum Reprod Open"},{"key":"2021071903190353000_hoab022-B31","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0140-6736(02)09417-5","article-title":"Female subfertility","volume":"360","author":"Evers","year":"2002","journal-title":"Lancet (London, England)"},{"key":"2021071903190353000_hoab022-B32","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1093\/humrep\/dew092","article-title":"Santa Claus in the fertility clinic","volume":"31","author":"Evers","year":"2016","journal-title":"Hum Reprod"},{"key":"2021071903190353000_hoab022-B33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.fertnstert.2020.04.054","article-title":"Which key performance indicators are most effective in evaluating and managing an in vitro fertilization laboratory?","volume":"114","author":"Fabozzi","year":"2020","journal-title":"Fertil Steril"},{"key":"2021071903190353000_hoab022-B34","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(05)67103-6","article-title":"Ectopic pregnancy","volume":"366","author":"Farquhar","year":"2005","journal-title":"Lancet (London, England)"},{"key":"2021071903190353000_hoab022-B35","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.rbmo.2018.12.032","article-title":"Individualization of the starting dose of follitropin delta reduces the overall OHSS risk and\/or the need for additional preventive interventions: cumulative data over three stimulation cycles","volume":"38","author":"Fernandez-Sanchez","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"2021071903190353000_hoab022-B36","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE consensus on the definition of \u2018poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Hum Reprod"},{"key":"2021071903190353000_hoab022-B37","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1093\/humrep\/del252","article-title":"Uro-retroperitoneum after ultrasound-guided transvaginal follicle puncture in an oocyte donor: a case report","volume":"21","author":"Fiori","year":"2006","journal-title":"Hum Reprod"},{"key":"2021071903190353000_hoab022-B38","doi-asserted-by":"crossref","first-page":"61","DOI":"10.5935\/1518-0557.20170016","article-title":"Key performance indicators score (KPIs-score) based on clinical and laboratorial parameters can establish benchmarks for internal quality control in an ART program","volume":"21","author":"Franco","year":"2017","journal-title":"JBRA Assist Reprod"},{"key":"2021071903190353000_hoab022-B39","doi-asserted-by":"crossref","DOI":"10.1093\/hropen\/hoz017","article-title":"Worldwide decline of IVF birth rates and its probable causes","volume":"2019","author":"Gleicher","year":"2019","journal-title":"Hum Reprod Open"},{"key":"2021071903190353000_hoab022-B40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149615","article-title":"Prediction of ovarian hyperstimulation syndrome in patients treated with corifollitropin alfa or rFSH in a GnRH antagonist protocol","volume":"11","author":"Griesinger","year":"2016","journal-title":"PLoS One"},{"key":"2021071903190353000_hoab022-B41","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/humrep\/dey349","article-title":"Tracking quality: can embryology key performance indicators be used to identify clinically relevant shifts in pregnancy rate?","volume":"34","author":"Hammond","year":"2019","journal-title":"Hum Reprod"},{"key":"2021071903190353000_hoab022-B42","volume-title":"To Err is Human: Building a Safer Health System","author":"Institute of Medicine Committee on Quality of Health Care in America","year":"2000"},{"key":"2021071903190353000_hoab022-B43","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0015-0282(16)48251-8","article-title":"Three years of in vitro fertilization at Norfolk","volume":"42","author":"Jones","year":"1984","journal-title":"Fertil Steril"},{"key":"2021071903190353000_hoab022-B44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/humrep\/deu262","article-title":"Overtreatment in couples with unexplained infertility","volume":"30","author":"Kersten","year":"2015","journal-title":"Hum Reprod"},{"key":"2021071903190353000_hoab022-B45","doi-asserted-by":"crossref","first-page":"e151; author reply e152","DOI":"10.1016\/j.fertnstert.2011.06.057","article-title":"A case of severe early-onset OHSS after GnRH-agonist triggering","volume":"96","author":"Kol","year":"2011","journal-title":"Fertil Steril"},{"key":"2021071903190353000_hoab022-B46","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/humupd\/dmx017","article-title":"GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type","volume":"23","author":"Lambalk","year":"2017","journal-title":"Hum Reprod Update"},{"key":"2021071903190353000_hoab022-B47","doi-asserted-by":"crossref","first-page":"e0186287","DOI":"10.1371\/journal.pone.0186287","article-title":"Advanced maternal age and adverse pregnancy outcomes: a systematic review and meta-analysis","volume":"12","author":"Lean","year":"2017","journal-title":"PLoS One"},{"key":"2021071903190353000_hoab022-B48","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.fertnstert.2018.02.002","article-title":"Appraisal of clinical complications after 23,827 oocyte retrievals in a large assisted reproductive technology program","volume":"109","author":"Levi-Setti","year":"2018","journal-title":"Fertil Steril"},{"key":"2021071903190353000_hoab022-B49","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1093\/humrep\/dev168","article-title":"Risk of ectopic pregnancy lowest with transfer of single frozen blastocyst","volume":"30","author":"Li","year":"2015","journal-title":"Hum Reprod"},{"key":"2021071903190353000_hoab022-B50","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.fertnstert.2008.10.028","article-title":"Ovarian hemorrhage after transvaginal ultrasonographically guided oocyte aspiration: a potentially catastrophic and not so rare complication among lean patients with polycystic ovary syndrome","volume":"93","author":"Liberty","year":"2010","journal-title":"Fertil Steril"},{"key":"2021071903190353000_hoab022-B51","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1136\/bmj.39317.641296.AD","article-title":"Use of process measures to monitor the quality of clinical practice","volume":"335","author":"Lilford","year":"2007","journal-title":"BMJ"},{"key":"2021071903190353000_hoab022-B52","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/obr.12455","article-title":"Association between perinatal outcomes and maternal pre-pregnancy body mass index. Obesity Rev: Official J Int Assoc Study","volume":"17","author":"Liu","year":"2016","journal-title":"Obes Rev"},{"key":"2021071903190353000_hoab022-B53","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.rbmo.2018.05.009","article-title":"Critical appraisal of the Vienna consensus: performance indicators for assisted reproductive technology laboratories","volume":"37","author":"Lopez-Regalado","year":"2018","journal-title":"Reprod Biomed Online"},{"key":"2021071903190353000_hoab022-B54","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/humrep\/deu080","article-title":"Individualized embryo transfer training: timing and performance","volume":"29","author":"Lopez","year":"2014","journal-title":"Hum Reprod"},{"key":"2021071903190353000_hoab022-B55","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1093\/humrep\/del278","article-title":"Perioperative and post-operative complications of transvaginal ultrasound-guided oocyte retrieval: prospective study of &gt;1000 oocyte retrievals","volume":"21","author":"Ludwig","year":"2006","journal-title":"Hum Reprod"},{"key":"2021071903190353000_hoab022-B56","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/humrep\/17.1.137","article-title":"Acute ureteral obstruction following transvaginal oocyte retrieval for IVF","volume":"17","author":"Miller","year":"2002","journal-title":"Hum Reprod"},{"key":"2021071903190353000_hoab022-B57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/humrep\/deh028","article-title":"What is the most relevant standard of success in assisted reproduction? The singleton, term gestation, live birth rate per cycle initiated: the BESST endpoint for assisted reproduction","volume":"19","author":"Min","year":"2004","journal-title":"Hum Reprod"},{"key":"2021071903190353000_hoab022-B58","doi-asserted-by":"crossref","first-page":"e10-11","DOI":"10.1016\/j.ajog.2007.01.025","article-title":"Von Willebrand disease presenting as recurrent hemorrhage after transvaginal oocyte retrieval","volume":"196","author":"Moayeri","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"2021071903190353000_hoab022-B59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5603\/GP.a2018.0001","article-title":"Evaluation of complications developing during and after transvaginal ultrasound \u2013 guided oocyte retrieval","volume":"89","author":"Ozaltin","year":"2018","journal-title":"Ginekol Pol"},{"key":"2021071903190353000_hoab022-B60","author":"Panayotidis","year":"2017"},{"key":"2021071903190353000_hoab022-B61","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/humrep\/deh638","article-title":"Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile","volume":"20","author":"Papanikolaou","year":"2005","journal-title":"Hum Reprod"},{"key":"2021071903190353000_hoab022-B62","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.fertnstert.2020.04.055","article-title":"Which key performance indicators are optimal to assess clinical management of assisted reproduction cycles?","volume":"114","author":"Pirtea","year":"2020","journal-title":"Fertil Steril"},{"key":"2021071903190353000_hoab022-B63","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.fertnstert.2012.05.032","article-title":"Diagnostic evaluation of the infertile female: a committee opinion","volume":"98","author":"Practice Committee of the American Society for Reproductive Medicine","year":"2012","journal-title":"Fertil Steril"},{"key":"2021071903190353000_hoab022-B64","author":"RCOG. Reproductive medicine curriculum and logbook","year":"2015"},{"key":"2021071903190353000_hoab022-B65","first-page":"Cd006606","article-title":"In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction","volume":"11","author":"Siristatidis","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2021071903190353000_hoab022-B66","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s10916-019-1340-3","article-title":"A pilot study on oocyte retrieval simulator: a new tool for training?","volume":"43","author":"Soave","year":"2019","journal-title":"J Med Syst"},{"key":"2021071903190353000_hoab022-B67","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/humrep\/der106","article-title":"Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles","volume":"26","author":"Sunkara","year":"2011","journal-title":"Hum Reprod"},{"key":"2021071903190353000_hoab022-B68","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1017\/9781107295391.015","volume-title":"Complications and Outcomes of Assisted Reproduction","author":"Tarlatzis","year":"2017"},{"key":"2021071903190353000_hoab022-B69","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-0036-1594000","article-title":"Using key performance indicators to do more with less in your practice","volume":"37","author":"Taylor","year":"2016","journal-title":"Semin Hear"},{"key":"2021071903190353000_hoab022-B70","article-title":"Terminology for describing normally-sited and ectopic pregnancies on ultrasound: ESHRE recommendations for good practice","author":"The ESHRE Guideline Group on Ectopic Pregnancy","year":"2020","journal-title":"HROPen \u2013 to Be Submitted"},{"key":"2021071903190353000_hoab022-B71","article-title":"ESHRE guideline: ovarian stimulation for IVF\/ICSI","volume":"2020","author":"Bosch","year":"2020","journal-title":"Hum Reprod Open 2020"},{"key":"2021071903190353000_hoab022-B72","doi-asserted-by":"crossref","DOI":"10.1093\/hropen\/hoaa032","article-title":"ART in Europe, 2016: results generated from European registries by ESHRE","volume":"2020","author":"Wyns","year":"2020","journal-title":"Hum Reprod Open"},{"key":"2021071903190353000_hoab022-B73","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.fertnstert.2007.12.048","article-title":"The empty follicle syndrome is dead!","volume":"89","author":"van Heusden","year":"2008","journal-title":"Fertil Steril"},{"key":"2021071903190353000_hoab022-B74","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.fertnstert.2010.06.048","article-title":"What do consistently high-performing in vitro fertilization programs in the U.S. do?","volume":"94","author":"Van Voorhis","year":"2010","journal-title":"Fertil Steril"},{"key":"2021071903190353000_hoab022-B75","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/bmjebm-2018-111032","article-title":"European Recommendations for good practice in addition to an evidence-based guidelines programme: rationale and method of development","volume":"24","author":"Vermeulen","year":"2019","journal-title":"BMJ Evid Based Med"},{"key":"2021071903190353000_hoab022-B76","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.rbmo.2017.03.017","article-title":"Cumulative live birth rate after GnRH agonist trigger and elective cryopreservation of all embryos in high responders","volume":"35","author":"Vlaisavljevic","year":"2017","journal-title":"Reprod Biomed Online"},{"key":"2021071903190353000_hoab022-B77","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2008.03.005","article-title":"Immediate ureterovaginal fistula secondary to oocyte retrieval\u2013a case report","volume":"90","author":"von Eye Corleta","year":"2008","journal-title":"Fertil Steril"},{"key":"2021071903190353000_hoab022-B78","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1093\/humrep\/dew227","article-title":"No common denominator: a review of outcome measures in IVF RCTs","volume":"31","author":"Wilkinson","year":"2016","journal-title":"Hum Reprod"},{"key":"2021071903190353000_hoab022-B79","author":"World Health Organization","year":"2010"},{"key":"2021071903190353000_hoab022-B80","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00404-018-4724-6","article-title":"Thawed embryo transfer and ectopic pregnancy: a meta-analysis","volume":"297","author":"Xing","year":"2018","journal-title":"Arch Gynecol Obstet"},{"key":"2021071903190353000_hoab022-B81","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/humrep\/dex234","article-title":"The International Glossary on Infertility and Fertility Care, 2017","volume":"32","author":"Zegers-Hochschild","year":"2017","journal-title":"Hum Reprod"}],"container-title":["Human Reproduction Open"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hropen\/article-pdf\/2021\/3\/hoab022\/39075783\/hoab022.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/hropen\/article-pdf\/2021\/3\/hoab022\/39075783\/hoab022.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T03:20:33Z","timestamp":1626664833000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hropen\/article\/doi\/10.1093\/hropen\/hoab022\/6314116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":81,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6,29]]}},"URL":"https:\/\/doi.org\/10.1093\/hropen\/hoab022","relation":{},"ISSN":["2399-3529"],"issn-type":[{"value":"2399-3529","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,6,1]]},"published":{"date-parts":[[2021,6,1]]},"article-number":"hoab022"}}